Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Vinicius Ortega Alves

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pediatric Clinics of North America|March 16, 2017
Adolescent PregnancyHeidi K Leftwich, Marcus Vinicius Ortega Alves
Molecular Cancer Therapeutics|July 11, 2013
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53Mayur A Gadhikar, Maria Rita Sciuto, Marcus Vinicius Ortega Alves, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pediatric Clinics of North America|March 16, 2017
Adolescent PregnancyHeidi K Leftwich, Marcus Vinicius Ortega Alves
Molecular Cancer Therapeutics|July 11, 2013
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53Mayur A Gadhikar, Maria Rita Sciuto, Marcus Vinicius Ortega Alves, et al.
Pageof 1